Krylov V V, Guekht A B, Trifonov I S, Lebedeva A V, Kaimovsky I L, Sinkin M V, Grigorieva E V, Grishkina M N, Shyshkina L V, Kochetkova O O
Evdokimov Moscow State University of Medical Dentisity, Moscow, Russia; Buyanov City Clinical Hospital, Moscow, Russia.
Sklifosovsky Emergensy Medicine Research Institute, Moscow, Russia; Moscow Research and Clinical Centre for Psychoneurology.
Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(9. Vyp. 2):13-18. doi: 10.17116/jnevro20161169213-18.
To evaluate the results of surgical treatment of patients with pharmacoresistant epilepsy.
Examination and surgical treatment of 61 patients with pharmacoresistant forms of symptomatic epilepsy were performed from 01.01.14 to 01.05.16.
The results confirmed the safety and efficacy of the surgical treatment of pharmacoresistant epilepsy. After 12 months, seizures were controlled in 69% of operated patients. The necessity of complex examination of all patients with pharmacoresistant epilepsy to make a decision about possible surgery is shown.
评估药物难治性癫痫患者的外科治疗效果。
2014年1月1日至2016年5月1日期间，对61例症状性药物难治性癫痫患者进行了检查和外科治疗。
结果证实了药物难治性癫痫外科治疗的安全性和有效性。12个月后，69%的手术患者癫痫发作得到控制。表明了对所有药物难治性癫痫患者进行综合检查以决定是否可行手术的必要性。
